Comparison of 2 Smart Watch Algorithms for Detection of Atrial Fibrillation and the Benefit of Clinician Interpretation

Ford, C. J. B.; Xie, Charis Xuan; Low, Ashlea; Rajakariar, K.; Koshy, A.; Sajeev, J.; Roberts, L.; Pathik, B.; Teh, A.

doi:10.1016/j.jacep.2022.02.013

Cited by 36 publications

(25 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Current literature has raised concern about the accuracy of wearables for AF detection as some validation studies have found notably worse performance compared with industry-reported data. 69,70 This highlights the need for rigorous, real-world validation studies in clinical settings.…”

Section: Wearables In Clinical Carementioning

confidence: 99%

Wearable Devices in Cardiovascular Medicine

Hughes

Shandhi

Master

et al. 2023

Circulation Research

View full text Add to dashboard Cite

Wearable devices, such as smartwatches and activity trackers, are commonly used by patients in their everyday lives to manage their health and well-being. These devices collect and analyze long-term continuous data on measures of behavioral or physiologic function, which may provide clinicians with a more comprehensive view of a patients’ health compared with the traditional sporadic measures captured by office visits and hospitalizations. Wearable devices have a wide range of potential clinical applications ranging from arrhythmia screening of high-risk individuals to remote management of chronic conditions such as heart failure or peripheral artery disease. As the use of wearable devices continues to grow, we must adopt a multifaceted approach with collaboration among all key stakeholders to effectively and safely integrate these technologies into routine clinical practice. In this Review, we summarize the features of wearable devices and associated machine learning techniques. We describe key research studies that illustrate the role of wearable devices in the screening and management of cardiovascular conditions and identify directions for future research. Last, we highlight the challenges that are currently hindering the widespread use of wearable devices in cardiovascular medicine and provide short- and long-term solutions to promote increased use of wearable devices in clinical care.

show abstract

Section: Wearables In Clinical Carementioning

confidence: 99%

Wearable Devices in Cardiovascular Medicine

Hughes

Shandhi

Master

et al. 2023

Circulation Research

View full text Add to dashboard Cite

show abstract

“…Due to the ease of use of smartwatches-initially aimed at consumers concerned about their own health-several studies have shown interest in their application for remote monitoring [8] and as a tool for telemonitoring and early detection of respiratory symptoms [9,10], heart disease [11][12][13][14], and remote physical therapy [15].…”

Section: Introductionmentioning

confidence: 99%

“…There are reports in the literature discussing smartwatch data collection [16], with the most recent already suggesting the possibility of early detection of COVID-19 [9,10] and atrial fibrillation [12][13][14]. However, for wearable devices to be really usable in a clinical setting, a digital platform that is easily accessible to health professionals is necessary.…”

Section: Introductionmentioning

confidence: 99%

Digital Platform to Continuously Monitor Patients Using a Smartwatch: Preliminary Report

Bin¹,

Pretto²,

Sanchez³

et al. 2022

JMIR Form Res

View full text Add to dashboard Cite

Background: Monitoring vital signs such as oximetry, blood pressure, and heart rate is important to follow the evolution of patients. Smartwatches are a revolution in medicine allowing the collection of such data in a continuous and organic way. However, it is still a challenge to make this information available to health care professionals to make decisions during clinical follow-up.Objective: This study aims to build a digital solution that displays vital sign data from smartwatches, collected remotely, continuously, reliably, and from multiple users, with trigger warnings when abnormal results are identified.Methods: This is a single-center prospective study following the guidelines "Evaluating digital health products" from the UK Health Security Agency. A digital platform with 3 different applications was created to capture and display data from the mobile phones of volunteers with smartwatches. We selected 80 volunteers who were followed for 24 weeks each, and the synchronization interval between the smartwatch and digital solution was recorded for each vital sign collected. Results: In 14 weeks of project progress, we managed to recruit 80 volunteers, with 68 already registered in the digital solution. More than 2.8 million records have already been collected, without system downtime. Less than 5% of continuous heart rate measurements (bpm) were synchronized within 2 hours. However, approximately 70% were synchronized in less than 24 hours, and 90% were synchronized in less than 119 hours. Conclusions:The digital solution is working properly in its role of displaying data collected from smartwatches. Vital sign values are being monitored by the research team as part of the monitoring of volunteers. Although the digital solution proved unsuitable for monitoring urgent events, it is more than suitable for use in outpatient clinical use. This digital solution, which is based on cloud technology, can be applied in the future for telemonitoring in regions lacking health care professionals. Accuracy and reliability studies still need to be performed at the end of the 24-week follow-up.

show abstract

“…However, most AF patients were in the dark until consumer ECG devices became available. 5 With the ability to measure ECGs at home and confirm AF, patients suddenly had opportunities to explore novel management strategies.…”

mentioning

confidence: 99%

“…Savvy patients might measure their own pulse, or perhaps use a home blood pressure monitoring device that could measure pulse irregularity. However, most AF patients were in the dark until consumer ECG devices became available 5 . With the ability to measure ECGs at home and confirm AF, patients suddenly had opportunities to explore novel management strategies.…”

mentioning

confidence: 99%

Using wearables to manage atrial fibrillation: Pushing the boundaries with consumer devices

Pérez

2023

Cardiovasc electrophysiol

View full text Add to dashboard Cite

The irregular pulse notification (IPN) algorithm on the Apple Watch (Apple Inc.) was not designed for use by atrial fibrillation (AF) patients. It is not Food and Drug Administration-cleared for use in AF patients. Before this study by Dr. Wasserlauf and colleagues, there were no studies of its accuracy in AF patients. Yet, many AF patients could not resist the temptation to use the feature. In the Apple Heart

show abstract

Comparison of 2 Smart Watch Algorithms for Detection of Atrial Fibrillation and the Benefit of Clinician Interpretation

Cited by 36 publications

References 22 publications

Wearable Devices in Cardiovascular Medicine

Wearable Devices in Cardiovascular Medicine

Digital Platform to Continuously Monitor Patients Using a Smartwatch: Preliminary Report

Using wearables to manage atrial fibrillation: Pushing the boundaries with consumer devices

Contact Info

Product

Resources

About